↓ Skip to main content

Uveal melanoma: From diagnosis to treatment and the science in between

Overview of attention for article published in Cancer (0008543X), March 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

news
3 news outlets
twitter
11 X users
patent
1 patent

Citations

dimensions_citation
285 Dimensions

Readers on

mendeley
321 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Uveal melanoma: From diagnosis to treatment and the science in between
Published in
Cancer (0008543X), March 2016
DOI 10.1002/cncr.29727
Pubmed ID
Authors

Chandrani Chattopadhyay, Dae Won Kim, Dan S Gombos, Junna Oba, Yong Qin, Michelle D Williams, Bita Esmaeli, Elizabeth A Grimm, Jennifer A Wargo, Scott E Woodman, Sapna P Patel

Abstract

Melanomas of the choroid, ciliary body, and iris of the eye are collectively known as uveal melanomas. These cancers represent 5% of all melanoma diagnoses in the United States, and their age-adjusted risk is 5 per 1 million population. These less frequent melanomas are dissimilar to their more common cutaneous melanoma relative, with differing risk factors, primary treatment, anatomic spread, molecular changes, and responses to systemic therapy. Once uveal melanoma becomes metastatic, therapy options are limited and are often extrapolated from cutaneous melanoma therapies despite the routine exclusion of patients with uveal melanoma from clinical trials. Clinical trials directed at uveal melanoma have been completed or are in progress, and data from these well designed investigations will help guide future directions in this orphan disease. Cancer 2016. © 2016 American Cancer Society.

X Demographics

X Demographics

The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 321 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 <1%
Netherlands 1 <1%
Portugal 1 <1%
Austria 1 <1%
Unknown 317 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 36 11%
Student > Ph. D. Student 35 11%
Student > Bachelor 33 10%
Researcher 30 9%
Student > Postgraduate 26 8%
Other 58 18%
Unknown 103 32%
Readers by discipline Count As %
Medicine and Dentistry 102 32%
Biochemistry, Genetics and Molecular Biology 49 15%
Agricultural and Biological Sciences 15 5%
Nursing and Health Professions 8 2%
Engineering 6 2%
Other 23 7%
Unknown 118 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 34. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 May 2023.
All research outputs
#1,192,514
of 25,837,817 outputs
Outputs from Cancer (0008543X)
#965
of 14,348 outputs
Outputs of similar age
#19,975
of 316,597 outputs
Outputs of similar age from Cancer (0008543X)
#27
of 123 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 14,348 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.4. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 316,597 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 123 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.